255 related articles for article (PubMed ID: 29855617)
21. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
Ashizawa M; Okayama H; Ishigame T; Thar Min AK; Saito K; Ujiie D; Murakami Y; Kikuchi T; Nakayama Y; Noda M; Tada T; Endo H; Fujita S; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
Mol Cancer Res; 2019 Jun; 17(6):1403-1413. PubMed ID: 30872332
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-93-5p expression in tumor tissue and its tumor suppressor function via targeting programmed death ligand-1 in colorectal cancer.
Chen YL; Wang GX; Lin BA; Huang JS
Cell Biol Int; 2020 May; 44(5):1224-1236. PubMed ID: 32068322
[TBL] [Abstract][Full Text] [Related]
23. Overexpressed circ_0067934 acts as an oncogene to facilitate cervical cancer progression via the miR-545/EIF3C axis.
Hu C; Wang Y; Li A; Zhang J; Xue F; Zhu L
J Cell Physiol; 2019 Jun; 234(6):9225-9232. PubMed ID: 30362562
[TBL] [Abstract][Full Text] [Related]
24. MiR-1266 promotes cell proliferation, migration and invasion in cervical cancer by targeting DAB2IP.
Wang J; Liu Y; Wang X; Li J; Wei J; Wang Y; Song W; Zhang Z
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3623-3630. PubMed ID: 30261286
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
Li YM; Li XJ; Yang HL; Zhang YB; Li JC
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
[TBL] [Abstract][Full Text] [Related]
27. LIN28/
Chen Y; Xie C; Zheng X; Nie X; Wang Z; Liu H; Zhao Y
Cancer Immunol Res; 2019 Mar; 7(3):487-497. PubMed ID: 30651289
[TBL] [Abstract][Full Text] [Related]
28. PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation.
Almozyan S; Colak D; Mansour F; Alaiya A; Al-Harazi O; Qattan A; Al-Mohanna F; Al-Alwan M; Ghebeh H
Int J Cancer; 2017 Oct; 141(7):1402-1412. PubMed ID: 28614911
[TBL] [Abstract][Full Text] [Related]
29. MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells.
Zuo Y; Zheng W; Liu J; Tang Q; Wang SS; Yang XS
Neoplasma; 2020 Jan; 67(1):93-101. PubMed ID: 31777260
[TBL] [Abstract][Full Text] [Related]
30. Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway.
Wang S; Li J; Xie J; Liu F; Duan Y; Wu Y; Huang S; He X; Wang Z; Wu X
Oncogene; 2018 Jul; 37(30):4164-4180. PubMed ID: 29706653
[TBL] [Abstract][Full Text] [Related]
31. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
Yang W; Xie T
Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
[TBL] [Abstract][Full Text] [Related]
32. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
33. MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer.
Li T; Zhou W; Li Y; Gan Y; Peng Y; Xiao Q; Ouyang C; Wu A; Zhang S; Liu J; Fan L; Han D; Wei Y; Shu G; Yin G
PLoS One; 2019; 14(4):e0214822. PubMed ID: 30939162
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis.
Su Y; Xiong J; Hu J; Wei X; Zhang X; Rao L
Oncotarget; 2016 Oct; 7(42):68397-68411. PubMed ID: 27588393
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.
Li GC; Cao XY; Li YN; Qiu YY; Li YN; Liu XJ; Sun XX
J Cell Physiol; 2018 Sep; 233(9):7379-7390. PubMed ID: 29575013
[TBL] [Abstract][Full Text] [Related]
36. Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2.
Ho JY; Hsu RJ; Wu CH; Liao GS; Gao HW; Wang TH; Yu CP
Oncotarget; 2016 Aug; 7(33):53853-53868. PubMed ID: 27462780
[TBL] [Abstract][Full Text] [Related]
37. microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6.
Chen Y; Song Y; Mi Y; Jin H; Cao J; Li H; Han L; Huang T; Zhang X; Ren S; Ma Q; Zou Z
Apoptosis; 2020 Apr; 25(3-4):205-216. PubMed ID: 31938895
[TBL] [Abstract][Full Text] [Related]
38. An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signalling.
Lin PL; Wu TC; Wu DW; Wang L; Chen CY; Lee H
Eur J Cancer; 2017 Nov; 85():95-105. PubMed ID: 28892778
[TBL] [Abstract][Full Text] [Related]
39. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
[TBL] [Abstract][Full Text] [Related]
40. miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint.
Li D; Wang X; Yang M; Kan Q; Duan Z
Exp Cell Res; 2019 Jul; 380(1):20-28. PubMed ID: 30904483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
